Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PARP inhibitors(Poly (ADP-Ribose) polymerase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lung Injury | Preclinical | United States | 12 Jul 2014 | |
Reperfusion Injury | Preclinical | United States | 21 Jul 2012 |